ヒストンメチルトランスフェラーゼSETDB1は,メラノーマで再発的に増幅され,発症を加速します
Craig J Ceol1, Yariv Houvras, Judit Jane-Valbuena
1Stem Cell Program and Hematology/Oncology, Children's Hospital Boston, Howard Hughes Medical Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
Nature
|March 25, 2011
まとめ
SETDB1は,腫瘍遺伝子として作用し,遺伝子発現を調節し損なうことで,メラノーマの形成を加速する. これは,BRAF変異と共に,がんの発症におけるクロマチン因子の役割を強調しています.
科学分野:
- 腫瘍学 腫瘍学
- 遺伝学 遺伝学とは
- 分子生物学は分子生物学である.
背景:
- BRAF (V600E) 変異はメラノーマでは一般的ですが,悪性腫瘍では不十分です.
- メラノマの発症には,腫瘍遺伝子の増幅など,追加の遺伝的変化が必要です.
- 増幅された領域における協力的な腫瘍性イベントの理解は,依然として困難です.
研究 の 目的:
- メラノーマを誘発するBRAF (V600E) と協力する遺伝子を特定する.
- メラノーマの病原性におけるSETDB1の役割を調査する.
主な方法:
- 斑馬魚のメラノーマモデルを利用した.
- 大規模な並列DNAシーケンシングと組み合わせたクロマチンの免疫プレシピテーションを使用しました.
- 遺伝子発現分析を行った.
主要な成果:
- SETDB1はゼブラフィッシュのメラノーマ形成を著しく加速した.
- SETDB1の過剰発現は,HOX遺伝子を含む遺伝子の転写不調を引き起こした.
- BRAF ((V600E)) と協力する腫瘍遺伝子としてSETDB1を特定しました.
結論:
- SETDB1は,メラノーマの発症を加速する腫瘍遺伝子です.
- クロマチン要因は,メラノーマ腫瘍発生において重要な役割を果たします.
- SETDB1は遺伝子発現を調節し,がんの進行に寄与する.
関連する概念動画
Electron Transport Chain: Complex I and II
11.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.9K
Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Loss of Tumor Suppressor Gene Functions
4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K


